Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
about
Acute promyelocytic leukemia: where did we start, where are we now, and the futureAcute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsImprovements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysisA review of arsenic trioxide and acute promyelocytic leukemiaTrends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.Curing all patients with acute promyelocytic leukemia: are we there yet?Acute myeloid leukemia, version 2.2013.Treatment advances have not improved the early death rate in acute promyelocytic leukemia.All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008.A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adultsPopulation-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysisClinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centreLethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia inductionClinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARAAcute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid eraClinical features and treatment outcome of acute promyelocytic leukemia patients treated at cairo national cancer institute in egypt.History of acute promyelocytic leukemia: a tale of endless revolutionAcute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.Acute myeloid leukemia in the real world: why population-based registries are needed.A Pediatric Acute Promyelocytic Leukemia With a Rare Karyotype of ider(17)(q10)t(15;17) and Favorable Outcome: A Case ReportDisparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in CaliforniaOutcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countriesNew strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.Massive Pulmonary Embolism at the Onset of Acute Promyelocytic LeukemiaHow I treat children and adolescents with acute promyelocytic leukaemia.Clinical characteristics of acute promyelocytic leukemia manifesting as early death.NLS‑RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway.Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.Bleeding and thrombosis in acute promyelocytic leukemia.Provocative pearls in diagnosing and treating acute promyelocytic leukemia.Acute myeloid leukemia: 2013 update on risk-stratification and management.Management of elderly patients with acute promyelocytic leukemia: progress and problems.Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.Contemporary treatment of APLProgress in the treatment of acute promyelocytic leukemia: optimization and obstruction.Management of acute myeloid leukemia during pregnancy.
P2860
Q26830385-0FD93CB5-DD46-4299-89D4-822A2EADD53AQ27009433-B5ABFA8D-86B2-4238-96D7-60F7DCE655EEQ27336142-EB1D0845-D47F-4AAE-AE01-45DF56437D13Q28087768-9DEC22DE-0F4B-4ABC-A988-C6F31F8D3864Q30540646-785EEDCE-753A-4BAE-BD20-5872A7574160Q33613426-6281BD64-F5C0-4068-B95E-C838A14B1D0EQ34165330-61BF7E5C-57B9-4130-A88A-D26F11E07D23Q34223654-3F309B54-ECA1-4E40-B6A6-E81D9EC9B6FFQ34240112-55B62AD3-F242-4BFD-9778-D7EBDDCB9F8FQ34267886-B44EC28A-5043-4E69-995A-9541AF8B6B9DQ34305899-F95197F1-2BCD-4481-A730-2642FA7E6BF3Q34428556-0819DFFA-556F-4158-840E-3DE26E184F68Q34953881-09386987-76A5-43BB-8A82-D6C8EACA1235Q35116492-3ECDEE26-5069-445D-879F-E84061C21C44Q35596919-B2E52FC7-8793-4DF0-A2EE-3F2EB2A5FC5CQ35640734-E798F1FB-7133-4DF6-BEA3-DDAD4BEC7756Q35640760-B7487A6B-FE14-4464-83AF-1EBFFC7A92D6Q35640780-28BE3B25-3A63-4E25-B934-3BEC9802261AQ35651744-9185E8DA-BACC-46D6-BDE1-417695D09A62Q35969759-516D00F9-F798-4166-AA6A-D25C1DDF5207Q35980291-6C1D962F-B59A-436E-92E2-6261C7DB5918Q36195613-7FACA6F8-8D9C-43C6-BFF1-5A350024899EQ36253767-0D22BF36-778E-4067-9E46-CD55EEFE452FQ36508333-2666338F-060E-48C6-9B32-054B292B980BQ36753253-65A185E6-3D83-4F02-9182-BB3198236D9FQ36941941-3FF66AB2-7C67-49E3-805F-DBEBB4F62139Q37055381-DFFAE3A9-DC26-4A00-854B-B3DF50B8622FQ37451376-98E1A2F2-824C-4820-B27B-7A15B890D0B6Q37559549-F04E8CFA-5058-40E7-B925-A9F5E4F78158Q37707549-F6387625-B7DF-4DAA-BD7D-802C0A15E029Q37712353-9AFB96E2-201A-44D2-B465-ADD0576ED703Q37952402-C88C2593-6111-402E-9EF8-1250F3E8600EQ38006876-630B9DBA-CE87-49DB-B4F6-F07AFB698624Q38034229-BEB01D2C-5DA4-4AFB-B07C-AA46CFEFCAC3Q38092771-2D3AFEFC-E29B-46AE-A6EE-54A3219A1E22Q38108471-CD5231C3-CE3D-46CB-B433-56B618FDFCF6Q38161835-5E9299D1-218B-4487-B317-E7B5D47B5CC3Q38197074-51B0AE7D-1B60-43CD-8506-0AD45986716DQ38221006-BACC82AC-2E2D-4225-8466-153BC4E75E04Q38232850-92857AC5-F303-4E81-9960-BDADAFC0CE7C
P2860
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early death rate in acute prom ...... espite all-trans retinoic acid
@en
Early death rate in acute prom ...... spite all-trans retinoic acid.
@nl
type
label
Early death rate in acute prom ...... espite all-trans retinoic acid
@en
Early death rate in acute prom ...... spite all-trans retinoic acid.
@nl
prefLabel
Early death rate in acute prom ...... espite all-trans retinoic acid
@en
Early death rate in acute prom ...... spite all-trans retinoic acid.
@nl
P2093
P2860
P1433
P1476
Early death rate in acute prom ...... espite all-trans retinoic acid
@en
P2093
Baozhen Qiao
Jacob M Rowe
Jae H Park
Jessica K Altman
Joseph G Jurcic
Katherine S Panageas
Maria J Schymura
Todd L Rosenblat
P2860
P304
P356
10.1182/BLOOD-2011-04-346437
P407
P577
2011-06-08T00:00:00Z